fbpx
  • Home
  • Study Details
Open

SARS-CoV-2 Vaccination in Immune-mediated Disease (no Vaccine provided)

To better understand how effective the COVID vaccine is in patients with autoimmune disease. **This study does not provide the COVID Vaccine*

Age & Gender

  • 2 years ~ 99 years
  • Male, Female, Gender Inclusive

Visit Availability

  • Standard business hours (M-F, 8-5)
  • Visits can be combined with regular clinical appointments

Location

United States (Nationwide)

What will be asked of you

At each visit we will obtain a sample of blood. Whenever possible, we will time these visits to coincide with your normal medical visits.

In-person visits:
4
Phone or online visits:
4
Total length of participation:
4 study visits over 15 months

Looking for Specific Volunteers

Able to participate:

  • Vasculitis, glomerular diseases, or other autoimmune diseases
  • Plan to receive vaccination 1-3 months following enrollment or have completed SARS-CoV-2 vaccination course within the prior 1-3 months.
  • *Please note: This study does not provide any vaccine*

Not eligible if:

  • History of splenectomy
  • History of cancer with exposure to chemotherapy in the last two years
  • Active COVID-19 infection
  • History of uncontrolled HBV and HCV, and HIV
  • Received blood, blood products, or IVIG in the last three months.

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Visit Study Website

Primary Visit Location

Eastowne Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Manish Saha
Medicine-Nephrology

Study Type

Clinical or Medical
Observational

Study Topics

Chronic Conditions
Healthy Volunteer or General Population
Immune System/Infections
Kidneys and Liver
Rare Diseases

IRB Number

21-0232

logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.